Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 6, 2012, Pages 633-639

  Huang, Xiaodan ^a   Ji, Jie ^b   Xue, Huiting ^a   Zhang, Faming ^a   Han, Xiang ^c   Cai, Yong ^c   Zhang, Jianhuai ^c   Ji, Guozhong ^a  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

cortactin; fascin; hepatocellular carcinoma; immunohistochemical; survival test

Indexed keywords

ALPHA FETOPROTEIN; CORTACTIN; FASCIN; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR THROMBUS; TUMOR VOLUME; UPREGULATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL DIFFERENTIATION; CORTACTIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861191745     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283515a18     Document Type: Article

References (17)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Tang ZY. Small hepatocellular carcinoma: current status and prospects. Hepatobiliary Pancreat Dis Int 2002;1:349-353.
3. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003;112:453-465.
4. Yamashiro S, Yamakita Y, Ono S, Matsumura F. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 1998;9:993-1006.
5. Jayo A, Parsons M. Fascin: a key regulator of cytoskeletal dynamics. Int J Biochem Cell Biol 2010;42:1614-1617.
6. Zhao Q, Shen JH, Shen ZY, Wu ZY, Xu XE, Xie JJ, et al. Phosphorylation of fascin decreases the risk of poor survival in patients with esophageal squamous cell carcinoma. J Histochem Cytochem 2010;58:979-988.
7. Oh SY, Kim YB, Suh KW, Paek OJ, Moon HY. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer. J Surg Res 2012;172:102-108.
8. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004;67:262-270.
9. Lee TK, Poon RT, Man K, Guan XY, Ma S, Liu XB, et al. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett 2007;254:308-315.
10. Kirkbride KC, Sung BH, Sinha S, Weaver AM. Cortactin: a multifunctional regulator of cellular invasiveness. Cell Adh Migr 2011;5:187-198.
11. Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi K, Tsuchiya A, et al. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 2004;41:629-636.
12. Cai JH, Zhao R, Zhu JW, Jin XL, Wan FJ, Liu K, et al. Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma. J Gastrointest Surg 2010;14:1248-1257.
13. Li X, Zheng H, Hara T, Takahashi H, Masuda S, Wang Z, et al. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Int J Oncol 2008;33:69-79.
14. Sheen-Chen SM, Huang CY, Liu YY, Huang CC, Tang RP. Cortactin in breast cancer: analysis with tissue microarray. Anticancer Res 2011;31:293-297.
15. Zhang FM, Ren G, Lu Y, Jin B, Wang J, Chen X, et al. Identification of TRAK1 (trafficking protein, kinesin-binding 1) as MGb2-Ag: a novel cancer biomarker. Cancer Lett 2009;274:250-258.
16. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
17. Bryan J, Kane RE. Separation and interaction of the major components of sea urchin actin gel. J Mol Biol 1978;125:207-224.